**Core Concept**
Endometrial carcinoma is a malignancy of the endometrium, the lining of the uterus. The histopathological classification of endometrial carcinoma is crucial for determining the prognosis and guiding treatment decisions.

**Why the Correct Answer is Right**
The correct answer is **Type I** endometrial carcinoma, which accounts for approximately 80-90% of cases. Type I endometrial carcinoma is characterized by a mutation in the PTEN gene, leading to the activation of the PI3K/AKT signaling pathway. This results in the overexpression of estrogen receptors (ER) and progesterone receptors (PR), making the tumor responsive to hormonal therapies. The tumor cells are typically endometrioid in type, with a low nuclear grade and a high level of differentiation.

**Why Each Wrong Option is Incorrect**
**Option A:** Type II endometrial carcinoma is a rare and aggressive subtype, accounting for approximately 10% of cases. It is characterized by a high-grade tumor with a loss of hormone receptor expression and a poor response to hormonal therapies.

**Option B:** Clear cell carcinoma is a rare subtype of endometrial carcinoma, accounting for approximately 2-5% of cases. It is characterized by a high nuclear grade and a poor response to hormonal therapies.

**Option C:** Serous carcinoma is a rare subtype of endometrial carcinoma, accounting for approximately 5-10% of cases. It is characterized by a high-grade tumor with a loss of hormone receptor expression and a poor response to hormonal therapies.

**Clinical Pearl / High-Yield Fact**
Type I endometrial carcinoma is often associated with a better prognosis and a higher response rate to hormonal therapies, such as tamoxifen and aromatase inhibitors. In contrast, Type II endometrial carcinoma is often associated with a poorer prognosis and a lower response rate to hormonal therapies.

**Correct Answer: A. Type I**